CHCT (Community Healthcare Trust Incorporated Common Stock, $0.01 par value per share)
Insider Trading Activity
Every open-market purchase and sale reported by CHCT officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-18 | Leigh Ann Stach | Executive Vice President & CAO | MIXED | — | — |
| 2026-08-18 | David H. Dupuy | CEO and President | A | — | — |
| 2026-08-18 | William G. IV Monroe | Executive Vice President & CFO | A | — | — |
| 2026-08-17 | David H. Dupuy | CEO and President | Buy | — | — |
| 2026-08-12 | Robert Z Hensley | Director | Buy | — | — |
| 2026-08-03 | David H. Dupuy | CEO and President | A | — | — |
| 2026-08-03 | Leigh Ann Stach | Executive Vice President & CAO | A | — | — |
| 2026-08-03 | William G. IV Monroe | Executive Vice President & CFO | A | — | — |
| 2026-07-02 | Leigh Ann Stach | Executive Vice President & CAO | F | — | — |
| 2026-07-02 | William G. IV Monroe | Executive Vice President & CFO | F | — | — |
| 2026-07-02 | David H. Dupuy | CEO and President | F | — | — |
| 2026-05-26 | R. Lawrence Van Horn | Director | A | — | — |
| 2026-05-26 | Alan Gardner | Director | A | — | — |
| 2026-05-26 | CLAIRE M GULMI | Director | A | — | — |
| 2026-05-26 | Robert Z Hensley | Director | A | — | — |
| 2026-05-26 | Cathrine Cotman | Director | A | — | — |
| 2026-05-08 | Cathrine Cotman | Director | A | — | — |
| 2026-05-08 | Alan Gardner | Director | A | — | — |
| 2026-05-08 | CLAIRE M GULMI | Director | A | — | — |
| 2026-05-08 | Robert Z Hensley | Director | A | — | — |
| 2026-05-08 | R. Lawrence Van Horn | Director | A | — | — |
| 2026-01-20 | David H. Dupuy | CEO and President | A | — | — |
| 2026-01-20 | William G. IV Monroe | Executive Vice President & CFO | A | — | — |
| 2026-01-20 | Leigh Ann Stach | Executive Vice President & CAO | MIXED | — | — |
| 2025-11-05 | Cathrine Cotman | Director | Buy | — | — |
| 2025-08-08 | William G. IV Monroe | Executive Vice President & CFO | A | — | — |
| 2025-08-08 | David H. Dupuy | CEO and President | A | — | — |
| 2025-08-08 | Leigh Ann Stach | Executive Vice President & CAO | A | — | — |
| 2025-07-28 | Leigh Ann Stach | Executive Vice President & CAO | A | — | — |
| 2025-07-28 | William G. IV Monroe | Executive Vice President & CFO | A | — | — |
| 2025-07-28 | David H. Dupuy | CEO and President | A | — | — |
| 2025-07-02 | David H. Dupuy | CEO and President | F | — | — |
| 2025-07-02 | Leigh Ann Stach | Executive Vice President & CAO | F | — | — |
| 2025-07-02 | William G. IV Monroe | Executive Vice President & CFO | F | — | — |
| 2025-06-03 | William G. IV Monroe | Executive Vice President & CFO | A | — | — |
| 2025-05-30 | R. Lawrence Van Horn | Director | Buy | — | — |
| 2025-05-16 | Robert Z Hensley | Director | A | — | — |
| 2025-05-16 | CLAIRE M GULMI | Director | A | — | — |
| 2025-05-16 | R. Lawrence Van Horn | Director | A | — | — |
| 2025-05-16 | Cathrine Cotman | Director | A | — | — |
| 2025-05-16 | Alan Gardner | Director | A | — | — |
| 2025-05-14 | David H. Dupuy | CEO and President | Buy | — | — |
| 2025-05-02 | Robert Z Hensley | Director | A | — | — |
| 2025-05-02 | R. Lawrence Van Horn | Director | A | — | — |
| 2025-05-02 | Alan Gardner | Director | A | — | — |
| 2025-05-02 | Cathrine Cotman | Director | MIXED | — | — |
| 2025-05-02 | CLAIRE M GULMI | Director | A | — | — |
| 2025-01-17 | William G. IV Monroe | Executive Vice President & CFO | A | — | — |
| 2025-01-17 | David H. Dupuy | CEO and President | A | — | — |
| 2025-01-17 | Timothy L. Meyer | EVP - Asset Management | A | — | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| — | Chairman, CEO and President | 1,183,201 | — |
| — | CEO and President | 584,115 | — |
| — | Executive Vice President & CAO | 475,955 | — |
| — | Executive Vice President & CFO | 255,912 | — |
| — | Executive Vice President & COO | 236,135 | — |
| — | EVP - Asset Management | 202,825 | — |
| — | Director | 104,521 | — |
| — | Director | 103,702 | — |
| — | Director | 102,385 | — |
| — | Director | 71,523 | — |
| — | Director | 49,893 | — |
| — | Director | 20,761 | — |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the CHCT quote page; the site-wide leaderboard is on the insider transactions hub.